The European Medicines Agency (EMA) is expected on Monday to issue a decision on its assessment of a COVID-19 vaccine developed by US drugmaker Pfizer and its German Partner BioNTech, with possible rollout across EU member states as of Sunday.

The evaluation meeting was brought forward a week, following increased pressure by Germany, whose Health Minister, Jens Spahn called for a market authorisation before Christmas. The approval could allow for countries to kickstart vaccinations before the end of the year.

Διαβάστε ακόμα